Ehrsson H - Search Results

1

The kinetics and cytotoxicity of cisplatin and its monohydrated complex.

Yachnin JR, Wallin I, Lewensohn R, Sirzén F, Ehrsson H. Yachnin JR, et al. Among authors: ehrsson h. Cancer Lett. 1998 Oct 23;132(1-2):175-80. doi: 10.1016/s0304-3835(98)00175-x. Cancer Lett. 1998. PMID: 10397471

2

Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig.

Ekborn A, Lindberg A, Laurell G, Wallin I, Eksborg S, Ehrsson H. Ekborn A, et al. Among authors: ehrsson h. Cancer Chemother Pharmacol. 2003 Jan;51(1):36-42. doi: 10.1007/s00280-002-0540-5. Epub 2002 Nov 2. Cancer Chemother Pharmacol. 2003. PMID: 12497204

3

Kinetics of Cisplatin and its monohydrated complex with sulfur-containing compounds designed for local otoprotective administration.

Videhult P, Laurell G, Wallin I, Ehrsson H. Videhult P, et al. Among authors: ehrsson h. Exp Biol Med (Maywood). 2006 Nov;231(10):1638-45. doi: 10.1177/153537020623101009. Exp Biol Med (Maywood). 2006. PMID: 17060685

4

Synthesis and cytotoxicity of the dihydrated complex of oxaliplatin.

Videhult P, Yachnin J, Jerremalm E, Lewensohn R, Ehrsson H. Videhult P, et al. Among authors: ehrsson h. Cancer Lett. 2002 Jun 28;180(2):191-4. doi: 10.1016/s0304-3835(02)00002-2. Cancer Lett. 2002. PMID: 12175551

5

Pharmacokinetics of cisplatin and its monohydrated complex in humans.

Andersson A, Fagerberg J, Lewensohn R, Ehrsson H. Andersson A, et al. Among authors: ehrsson h. J Pharm Sci. 1996 Aug;85(8):824-7. doi: 10.1021/js960037a. J Pharm Sci. 1996. PMID: 8863271

6

D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics.

Ekborn A, Laurell G, Johnström P, Wallin I, Eksborg S, Ehrsson H. Ekborn A, et al. Among authors: ehrsson h. Hear Res. 2002 Mar;165(1-2):53-61. doi: 10.1016/s0378-5955(02)00277-0. Hear Res. 2002. PMID: 12031515

7

Liquid chromatographic determination of oxaliplatin in blood using post-column derivatization in a microwave field followed by photometric detection.

Ehrsson H, Wallin I. Ehrsson H, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Oct 5;795(2):291-4. doi: 10.1016/s1570-0232(03)00590-7. J Chromatogr B Analyt Technol Biomed Life Sci. 2003. PMID: 14522033

8

Oxaliplatin degradation in the presence of chloride: identification and cytotoxicity of the monochloro monooxalato complex.

Jerremalm E, Hedeland M, Wallin I, Bondesson U, Ehrsson H. Jerremalm E, et al. Among authors: ehrsson h. Pharm Res. 2004 May;21(5):891-4. doi: 10.1023/b:pham.0000026444.67883.83. Pharm Res. 2004. PMID: 15180350

9

High-dose Cisplatin with amifostine: ototoxicity and pharmacokinetics.

Ekborn A, Hansson J, Ehrsson H, Eksborg S, Wallin I, Wagenius G, Laurell G. Ekborn A, et al. Among authors: ehrsson h. Laryngoscope. 2004 Sep;114(9):1660-7. doi: 10.1097/00005537-200409000-00030. Laryngoscope. 2004. PMID: 15475801

10

Oxaliplatin degradation in the presence of important biological sulphur-containing compounds and plasma ultrafiltrate.

Jerremalm E, Wallin I, Yachnin J, Ehrsson H. Jerremalm E, et al. Among authors: ehrsson h. Eur J Pharm Sci. 2006 Jul;28(4):278-83. doi: 10.1016/j.ejps.2006.03.001. Epub 2006 Apr 18. Eur J Pharm Sci. 2006. PMID: 16621479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters